Uniform multidrug therapy for leprosy patients in Brazil (U-MDT/CT-BR): Results of an open label, randomized and controlled clinical trial, among multibacillary patients.
about
New perspectives for the treatment of Hansen's disease.Leprosy: current situation, clinical and laboratory aspects, treatment history and perspective of the uniform multidrug therapy for all patients.Mycobacterium leprae-Specific Antibodies in Multibacillary Leprosy Patients Decrease During and After Treatment With Either the Regular 12 Doses Multidrug Therapy (MDT) or the Uniform 6 Doses MDT.Reply of the authors of the Continuing Medical Education article to Dr. Jaison Barreto and Dr. Laila Laguiche
P2860
Uniform multidrug therapy for leprosy patients in Brazil (U-MDT/CT-BR): Results of an open label, randomized and controlled clinical trial, among multibacillary patients.
description
2017 nî lūn-bûn
@nan
2017年の論文
@ja
2017年論文
@yue
2017年論文
@zh-hant
2017年論文
@zh-hk
2017年論文
@zh-mo
2017年論文
@zh-tw
2017年论文
@wuu
2017年论文
@zh
2017年论文
@zh-cn
name
Uniform multidrug therapy for ...... among multibacillary patients.
@en
Uniform multidrug therapy for ...... among multibacillary patients.
@nl
type
label
Uniform multidrug therapy for ...... among multibacillary patients.
@en
Uniform multidrug therapy for ...... among multibacillary patients.
@nl
prefLabel
Uniform multidrug therapy for ...... among multibacillary patients.
@en
Uniform multidrug therapy for ...... among multibacillary patients.
@nl
P2093
P2860
P50
P1476
Uniform multidrug therapy for ...... among multibacillary patients.
@en
P2093
Ana Regina Coelho de Andrade
Andrea Machado Coelho Ramos
Heitor de Sá Gonçalves
Laura Cunha Rodrigues
Marcelo Grossi de Araújo
Maria Araci de Andrade Pontes
Maria Lúcia Fernandes Penna
Mariane Martins de Araújo Stefani
Maurício Barcelos Costa
Patricia Sammarco Rosa
P2860
P304
P356
10.1371/JOURNAL.PNTD.0005725
P407
P50
P577
2017-07-13T00:00:00Z